Alliancebernstein L.P. Gilead Sciences, Inc. Put Options Transaction History
Alliancebernstein L.P.
- $290 Billion
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding GILD
# of Institutions
2,352Shares Held
1.02BCall Options Held
12.1MPut Options Held
9.13M-
Black Rock Inc. New York, NY121MShares$14.7 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA119MShares$14.6 Billion0.22% of portfolio
-
State Street Corp Boston, MA59.2MShares$7.22 Billion0.25% of portfolio
-
Capital World Investors Los Angeles, CA46.3MShares$5.65 Billion0.78% of portfolio
-
Wellington Management Group LLP Boston, MA37.5MShares$4.58 Billion0.79% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $153B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...